Meetings: National Institute of Allergy and Infectious Diseases,

Federal Register, October 15, 2001 (Nbr. Vol. 66, No. 199)

Notices - National Institutes of Health
Permanent Link: http://regulations.vlex.com/vid/institute-allergy-infectious-diseases-22958709
Id. vLex: VLEX-22958709

Click here to download this article in graphic format (Acrobat Reader)

Search in this disposition

Go to article

Sponsored Ads:


Text:

Federal Register: October 15, 2001 (Volume 66, Number 199)NoticesPage 52438From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr15oc01-85

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel.

Date: November 1-2, 2001.

Time: November 1, 2001, 8 AM to adjournment.

Agenda: To review and evaluate grant applications.

Place: Holiday Inn, 5520 Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Anthony Macaluso, PhD, Scientific Review Administrator, NIAID/DEA, Scientific Review Program, Room 2212, 6700B Rockledge Drive, MSC-7616, Bethesda, MD 20892-7616, 301-496- 7465, amacaluso@niaid.nih.gov

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: October 4, 2001. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy.

FR Doc. 01-25822Filed10-12-01; 8:45 amBILLING CODE 4140-01-M